GlassScriptPhysician profile
Andrew J Meyer
NPI 1063868396
$3,943.11
in general payments reported to CMS, 2019-2025
22 companies · $62.75 in 2025
The $62.75 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $29.11 · 2020: $178 · 2021: $1,341 · 2022: $71.66 · 2023: $357 · 2024: $1,905 · 2025: $62.75.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,325 · Food and Beverage: $782 · Long Term Medical Supply Or Device Loan: $218.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,324.65 |
| Food and Beverage | $781.68 |
| Long Term Medical Supply Or Device Loan | $217.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Crossroads Orthopedics, LLC | $2,375.92 | 2021-2024 | |
| Paragon 28, INC. | $298.36 | 2023-2024 | Portfolio, Precision Mis Bunion, Mtp |
| Arthrex, INC. | $292.65 | 2024 | |
| Integra Lifesciences Corporation | $262.22 | 2020-2024 | Acell |
| Stryker Corporation | $158.52 | 2020-2025 | Citrefix, 7 X 23mm Citrelock Implant, Prostep |
| Paratek Pharmaceuticals, INC. | $91.94 | 2019-2022 | |
| Smith+Nephew, INC. | $82.76 | 2019-2024 | Oasis, Grafix Pl |
| Mimedx Group, INC. | $61.14 | 2024-2025 | |
| Zimmer Biomet Holdings, INC. | $42.25 | 2020-2021 | |
| Organogenesis INC. | $41.45 | 2023 | Puraply |
| Depuy Synthes Sales INC. | $32.37 | 2023 | Motoband |
| Tactile Systems Technology INC | $28.59 | 2024 | Flexitouch Plus, Entre Plus |
| Anika Therapeutics, INC. | $28.47 | 2021 | |
| Treace Medical Concepts, INC. | $25.12 | 2024 | |
| Bioventus LLC | $23.83 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Averitas Pharma INC. | $23.53 | 2023 | Qutenza |
| Reprise Biomedical, INC. | $16.65 | 2021 | |
| Biocomposites INC | $16.40 | 2024 | |
| Arthrosurface Incorporated | $11.93 | 2020 | |
| Tenex Health INC. | $11.84 | 2021 | |
| Triad Life Sciences INC. | $11.06 | 2021 | |
| Orthofix Medical, INC. | $6.11 | 2025 | Physio-Stim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Meyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.